CCL28 and COVID-19: From this analysis, Figure 5C showed four individual chemokines with significant change in COVID‐19 (CCL4, CCL‐11, CCL‐20 and CCL‐28), which could determine the immune status of the respiratory tract with two chemokines being mucosal (CCL20) and columnar epithelium (CCL11) specific.